Hofseth BioCare ASA (HOFBF)
- Previous Close
0.0000 - Open
0.1760 - Bid --
- Ask --
- Day's Range
0.1760 - 0.1760 - 52 Week Range
0.0950 - 0.2034 - Volume
67,500 - Avg. Volume
6 - Market Cap (intraday)
78.06M - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Hofseth BioCare ASA engages in the production of health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for weight management, and metabolism; CalGo, a calcium collagen complex for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was founded in 2000 and is headquartered in Ålesund, Norway.
www.hofsethbiocare.comRecent News: HOFBF
View MorePerformance Overview: HOFBF
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HOFBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HOFBF
View MoreValuation Measures
Market Cap
80.24M
Enterprise Value
94.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.56
Price/Book (mrq)
10.57
Enterprise Value/Revenue
3.83
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-47.19%
Return on Assets (ttm)
-18.00%
Return on Equity (ttm)
-249.37%
Revenue (ttm)
265.54M
Net Income Avi to Common (ttm)
-125.3M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
25.58M
Total Debt/Equity (mrq)
287.89%
Levered Free Cash Flow (ttm)
21.85M